BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200415T120000
DTEND;TZID=America/Vancouver:20200415T130000
DTSTAMP:20260408T151417
CREATED:20200323T175458Z
LAST-MODIFIED:20200323T175458Z
UID:10753-1586952000-1586955600@scienceinvancouver.com
SUMMARY:WEBINAR: The Modern Mentor
DESCRIPTION:Mentorship has transformative power. In today’s business world\, it has proven to be a critical element of success by getting people in positions of influence actively supporting\, sponsoring and guiding the careers of women as they progress through their careers\, particularly at pivotal decision points. However\, asking someone to mentor you and managing that relationship could be at times nerve-wracking. \nWCT is excited to offer a webinar that will help mentors and mentees achieve the most from any mentorship engagement. Fiona Gao\, a global marketing leader\, and Angela Brown\, President and CEO of Moneris\, recently participated in the WCT Protégé Project. Based on their experience\, they have released a white paper entitled “The Modern Mentor: Reimagining the Interconnectedness of Women in Business\,” which provides excellent advice for those in a mentorship or sponsorship relationship. \nDate: April 15\, 2020\nTime: 12pm-1pm\nRegister: here
URL:https://scienceinvancouver.com/event/webinar-the-modern-mentor/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200415T120000
DTEND;TZID=America/Vancouver:20200415T130000
DTSTAMP:20260408T151417
CREATED:20200323T175458Z
LAST-MODIFIED:20200323T175458Z
UID:26102-1586952000-1586955600@scienceinvancouver.com
SUMMARY:WEBINAR: The Modern Mentor
DESCRIPTION:Mentorship has transformative power. In today’s business world\, it has proven to be a critical element of success by getting people in positions of influence actively supporting\, sponsoring and guiding the careers of women as they progress through their careers\, particularly at pivotal decision points. However\, asking someone to mentor you and managing that relationship could be at times nerve-wracking. \nWCT is excited to offer a webinar that will help mentors and mentees achieve the most from any mentorship engagement. Fiona Gao\, a global marketing leader\, and Angela Brown\, President and CEO of Moneris\, recently participated in the WCT Protégé Project. Based on their experience\, they have released a white paper entitled “The Modern Mentor: Reimagining the Interconnectedness of Women in Business\,” which provides excellent advice for those in a mentorship or sponsorship relationship. \nDate: April 15\, 2020\nTime: 12pm-1pm\nRegister: here
URL:https://scienceinvancouver.com/event/webinar-the-modern-mentor-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200415T120000
DTEND;TZID=America/Vancouver:20200415T130000
DTSTAMP:20260408T151417
CREATED:20200323T175458Z
LAST-MODIFIED:20200323T175458Z
UID:27728-1586952000-1586955600@scienceinvancouver.com
SUMMARY:WEBINAR: The Modern Mentor
DESCRIPTION:Mentorship has transformative power. In today’s business world\, it has proven to be a critical element of success by getting people in positions of influence actively supporting\, sponsoring and guiding the careers of women as they progress through their careers\, particularly at pivotal decision points. However\, asking someone to mentor you and managing that relationship could be at times nerve-wracking. \nWCT is excited to offer a webinar that will help mentors and mentees achieve the most from any mentorship engagement. Fiona Gao\, a global marketing leader\, and Angela Brown\, President and CEO of Moneris\, recently participated in the WCT Protégé Project. Based on their experience\, they have released a white paper entitled “The Modern Mentor: Reimagining the Interconnectedness of Women in Business\,” which provides excellent advice for those in a mentorship or sponsorship relationship. \nDate: April 15\, 2020\nTime: 12pm-1pm\nRegister: here
URL:https://scienceinvancouver.com/event/webinar-the-modern-mentor-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200415T120000
DTEND;TZID=America/Vancouver:20200415T130000
DTSTAMP:20260408T151417
CREATED:20200323T175458Z
LAST-MODIFIED:20200323T175458Z
UID:30811-1586952000-1586955600@scienceinvancouver.com
SUMMARY:WEBINAR: The Modern Mentor
DESCRIPTION:Mentorship has transformative power. In today’s business world\, it has proven to be a critical element of success by getting people in positions of influence actively supporting\, sponsoring and guiding the careers of women as they progress through their careers\, particularly at pivotal decision points. However\, asking someone to mentor you and managing that relationship could be at times nerve-wracking. \nWCT is excited to offer a webinar that will help mentors and mentees achieve the most from any mentorship engagement. Fiona Gao\, a global marketing leader\, and Angela Brown\, President and CEO of Moneris\, recently participated in the WCT Protégé Project. Based on their experience\, they have released a white paper entitled “The Modern Mentor: Reimagining the Interconnectedness of Women in Business\,” which provides excellent advice for those in a mentorship or sponsorship relationship. \nDate: April 15\, 2020\nTime: 12pm-1pm\nRegister: here
URL:https://scienceinvancouver.com/event/webinar-the-modern-mentor-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200415T120000
DTEND;TZID=America/Vancouver:20200415T130000
DTSTAMP:20260408T151417
CREATED:20200323T175458Z
LAST-MODIFIED:20200323T175458Z
UID:32271-1586952000-1586955600@scienceinvancouver.com
SUMMARY:WEBINAR: The Modern Mentor
DESCRIPTION:Mentorship has transformative power. In today’s business world\, it has proven to be a critical element of success by getting people in positions of influence actively supporting\, sponsoring and guiding the careers of women as they progress through their careers\, particularly at pivotal decision points. However\, asking someone to mentor you and managing that relationship could be at times nerve-wracking. \nWCT is excited to offer a webinar that will help mentors and mentees achieve the most from any mentorship engagement. Fiona Gao\, a global marketing leader\, and Angela Brown\, President and CEO of Moneris\, recently participated in the WCT Protégé Project. Based on their experience\, they have released a white paper entitled “The Modern Mentor: Reimagining the Interconnectedness of Women in Business\,” which provides excellent advice for those in a mentorship or sponsorship relationship. \nDate: April 15\, 2020\nTime: 12pm-1pm\nRegister: here
URL:https://scienceinvancouver.com/event/webinar-the-modern-mentor-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T100000
DTEND;TZID=America/Vancouver:20200416T120000
DTSTAMP:20260408T151417
CREATED:20200326T171503Z
LAST-MODIFIED:20200326T171503Z
UID:10824-1587031200-1587038400@scienceinvancouver.com
SUMMARY:Webinar: Research Update from the BC-HTC and Community Implications
DESCRIPTION:On April 16th at 10 AM\, PAN is excited to host the “Research update from the BC Hepatitis Testers Cohort & highlights from the 2020 CanHepC Symposium & Canadian Liver Meeting: Implications for community & frontline providers” \nEach presenter will summarize the findings from their research that they presented at the 2020 CanHepC Symposium and Canadian Liver Meeting\, as well as summaries of findings from other BC-HTC research that was presented\, and their highlights from other presentations at the conference. \nTopics:\n\nMonitoring progress towards hepatitis C elimination\nAccess to hepatitis C testing & treatment among People in Prison and People Who Use Drugs\nBurden of hepatitis C infection and extra-hepatic manifestations\nMortality associated with hepatitis C infection\n\nPresenters:\n\nDr. Prince Adu- Postdoctoral Fellow at UBC School of Population and Public Health & BC-HTC at the BCCDC\nDahn Jeong- PhD Student at UBC School of Population and Public Health & BC Hepatitis Testers Cohort (BC-HTC) at the BC Centre for Disease Control (BCCDC)\nEmilia Clementi- Masters Student at UBC School of Population and Public Health & BC-HTC at the BCCDCDr.\nSofia Bartlett- Postdoctoral Fellow at UBC School of Pathology & Laboratory Medicine & BC-HTC at the BCCDC\n\nThere will be a Q&A at the end of the session. \nDetails:\nDate: Thursday April 16\, 2020\nTime: 10 -11:30 AM Pacific time \nSuggested audience:\n\nHIV and hepatitis C organization staff and volunteers\, including harm reduction workers\nCommunity members and other allies\nResearchers\nPeople interested in the epidemiology of infectious disease in BC\n\nPlease read this before you register\nAfter registration you should receive a confirmation email. SAVE THE CONFIRMATION EMAIL as it provides your unique link to get into the webinar. Check your Junk folder in email if it doesn’t arrive within an hour. \nIf you DO NOT receive an email within an hour of registering\, please EMAIL simon@pacificaidsnetwork.org as soon as you realize this. We won’t be able to provide access to links on the morning of the webinar as we will be setting up. \nRegister HERE
URL:https://scienceinvancouver.com/event/webinar-research-update-from-the-bc-htc-and-community-implications/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/BCHTC-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T100000
DTEND;TZID=America/Vancouver:20200416T120000
DTSTAMP:20260408T151417
CREATED:20200326T171503Z
LAST-MODIFIED:20200326T171503Z
UID:26111-1587031200-1587038400@scienceinvancouver.com
SUMMARY:Webinar: Research Update from the BC-HTC and Community Implications
DESCRIPTION:On April 16th at 10 AM\, PAN is excited to host the “Research update from the BC Hepatitis Testers Cohort & highlights from the 2020 CanHepC Symposium & Canadian Liver Meeting: Implications for community & frontline providers” \nEach presenter will summarize the findings from their research that they presented at the 2020 CanHepC Symposium and Canadian Liver Meeting\, as well as summaries of findings from other BC-HTC research that was presented\, and their highlights from other presentations at the conference. \nTopics:\n\nMonitoring progress towards hepatitis C elimination\nAccess to hepatitis C testing & treatment among People in Prison and People Who Use Drugs\nBurden of hepatitis C infection and extra-hepatic manifestations\nMortality associated with hepatitis C infection\n\nPresenters:\n\nDr. Prince Adu- Postdoctoral Fellow at UBC School of Population and Public Health & BC-HTC at the BCCDC\nDahn Jeong- PhD Student at UBC School of Population and Public Health & BC Hepatitis Testers Cohort (BC-HTC) at the BC Centre for Disease Control (BCCDC)\nEmilia Clementi- Masters Student at UBC School of Population and Public Health & BC-HTC at the BCCDCDr.\nSofia Bartlett- Postdoctoral Fellow at UBC School of Pathology & Laboratory Medicine & BC-HTC at the BCCDC\n\nThere will be a Q&A at the end of the session. \nDetails:\nDate: Thursday April 16\, 2020\nTime: 10 -11:30 AM Pacific time \nSuggested audience:\n\nHIV and hepatitis C organization staff and volunteers\, including harm reduction workers\nCommunity members and other allies\nResearchers\nPeople interested in the epidemiology of infectious disease in BC\n\nPlease read this before you register\nAfter registration you should receive a confirmation email. SAVE THE CONFIRMATION EMAIL as it provides your unique link to get into the webinar. Check your Junk folder in email if it doesn’t arrive within an hour. \nIf you DO NOT receive an email within an hour of registering\, please EMAIL simon@pacificaidsnetwork.org as soon as you realize this. We won’t be able to provide access to links on the morning of the webinar as we will be setting up. \nRegister HERE
URL:https://scienceinvancouver.com/event/webinar-research-update-from-the-bc-htc-and-community-implications-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/BCHTC-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T100000
DTEND;TZID=America/Vancouver:20200416T120000
DTSTAMP:20260408T151417
CREATED:20200326T171503Z
LAST-MODIFIED:20200326T171503Z
UID:27733-1587031200-1587038400@scienceinvancouver.com
SUMMARY:Webinar: Research Update from the BC-HTC and Community Implications
DESCRIPTION:On April 16th at 10 AM\, PAN is excited to host the “Research update from the BC Hepatitis Testers Cohort & highlights from the 2020 CanHepC Symposium & Canadian Liver Meeting: Implications for community & frontline providers” \nEach presenter will summarize the findings from their research that they presented at the 2020 CanHepC Symposium and Canadian Liver Meeting\, as well as summaries of findings from other BC-HTC research that was presented\, and their highlights from other presentations at the conference. \nTopics:\n\nMonitoring progress towards hepatitis C elimination\nAccess to hepatitis C testing & treatment among People in Prison and People Who Use Drugs\nBurden of hepatitis C infection and extra-hepatic manifestations\nMortality associated with hepatitis C infection\n\nPresenters:\n\nDr. Prince Adu- Postdoctoral Fellow at UBC School of Population and Public Health & BC-HTC at the BCCDC\nDahn Jeong- PhD Student at UBC School of Population and Public Health & BC Hepatitis Testers Cohort (BC-HTC) at the BC Centre for Disease Control (BCCDC)\nEmilia Clementi- Masters Student at UBC School of Population and Public Health & BC-HTC at the BCCDCDr.\nSofia Bartlett- Postdoctoral Fellow at UBC School of Pathology & Laboratory Medicine & BC-HTC at the BCCDC\n\nThere will be a Q&A at the end of the session. \nDetails:\nDate: Thursday April 16\, 2020\nTime: 10 -11:30 AM Pacific time \nSuggested audience:\n\nHIV and hepatitis C organization staff and volunteers\, including harm reduction workers\nCommunity members and other allies\nResearchers\nPeople interested in the epidemiology of infectious disease in BC\n\nPlease read this before you register\nAfter registration you should receive a confirmation email. SAVE THE CONFIRMATION EMAIL as it provides your unique link to get into the webinar. Check your Junk folder in email if it doesn’t arrive within an hour. \nIf you DO NOT receive an email within an hour of registering\, please EMAIL simon@pacificaidsnetwork.org as soon as you realize this. We won’t be able to provide access to links on the morning of the webinar as we will be setting up. \nRegister HERE
URL:https://scienceinvancouver.com/event/webinar-research-update-from-the-bc-htc-and-community-implications-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/BCHTC-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T100000
DTEND;TZID=America/Vancouver:20200416T120000
DTSTAMP:20260408T151417
CREATED:20200326T171503Z
LAST-MODIFIED:20200326T171503Z
UID:30816-1587031200-1587038400@scienceinvancouver.com
SUMMARY:Webinar: Research Update from the BC-HTC and Community Implications
DESCRIPTION:On April 16th at 10 AM\, PAN is excited to host the “Research update from the BC Hepatitis Testers Cohort & highlights from the 2020 CanHepC Symposium & Canadian Liver Meeting: Implications for community & frontline providers” \nEach presenter will summarize the findings from their research that they presented at the 2020 CanHepC Symposium and Canadian Liver Meeting\, as well as summaries of findings from other BC-HTC research that was presented\, and their highlights from other presentations at the conference. \nTopics:\n\nMonitoring progress towards hepatitis C elimination\nAccess to hepatitis C testing & treatment among People in Prison and People Who Use Drugs\nBurden of hepatitis C infection and extra-hepatic manifestations\nMortality associated with hepatitis C infection\n\nPresenters:\n\nDr. Prince Adu- Postdoctoral Fellow at UBC School of Population and Public Health & BC-HTC at the BCCDC\nDahn Jeong- PhD Student at UBC School of Population and Public Health & BC Hepatitis Testers Cohort (BC-HTC) at the BC Centre for Disease Control (BCCDC)\nEmilia Clementi- Masters Student at UBC School of Population and Public Health & BC-HTC at the BCCDCDr.\nSofia Bartlett- Postdoctoral Fellow at UBC School of Pathology & Laboratory Medicine & BC-HTC at the BCCDC\n\nThere will be a Q&A at the end of the session. \nDetails:\nDate: Thursday April 16\, 2020\nTime: 10 -11:30 AM Pacific time \nSuggested audience:\n\nHIV and hepatitis C organization staff and volunteers\, including harm reduction workers\nCommunity members and other allies\nResearchers\nPeople interested in the epidemiology of infectious disease in BC\n\nPlease read this before you register\nAfter registration you should receive a confirmation email. SAVE THE CONFIRMATION EMAIL as it provides your unique link to get into the webinar. Check your Junk folder in email if it doesn’t arrive within an hour. \nIf you DO NOT receive an email within an hour of registering\, please EMAIL simon@pacificaidsnetwork.org as soon as you realize this. We won’t be able to provide access to links on the morning of the webinar as we will be setting up. \nRegister HERE
URL:https://scienceinvancouver.com/event/webinar-research-update-from-the-bc-htc-and-community-implications-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/BCHTC-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T100000
DTEND;TZID=America/Vancouver:20200416T120000
DTSTAMP:20260408T151417
CREATED:20200326T171503Z
LAST-MODIFIED:20200326T171503Z
UID:32276-1587031200-1587038400@scienceinvancouver.com
SUMMARY:Webinar: Research Update from the BC-HTC and Community Implications
DESCRIPTION:On April 16th at 10 AM\, PAN is excited to host the “Research update from the BC Hepatitis Testers Cohort & highlights from the 2020 CanHepC Symposium & Canadian Liver Meeting: Implications for community & frontline providers” \nEach presenter will summarize the findings from their research that they presented at the 2020 CanHepC Symposium and Canadian Liver Meeting\, as well as summaries of findings from other BC-HTC research that was presented\, and their highlights from other presentations at the conference. \nTopics:\n\nMonitoring progress towards hepatitis C elimination\nAccess to hepatitis C testing & treatment among People in Prison and People Who Use Drugs\nBurden of hepatitis C infection and extra-hepatic manifestations\nMortality associated with hepatitis C infection\n\nPresenters:\n\nDr. Prince Adu- Postdoctoral Fellow at UBC School of Population and Public Health & BC-HTC at the BCCDC\nDahn Jeong- PhD Student at UBC School of Population and Public Health & BC Hepatitis Testers Cohort (BC-HTC) at the BC Centre for Disease Control (BCCDC)\nEmilia Clementi- Masters Student at UBC School of Population and Public Health & BC-HTC at the BCCDCDr.\nSofia Bartlett- Postdoctoral Fellow at UBC School of Pathology & Laboratory Medicine & BC-HTC at the BCCDC\n\nThere will be a Q&A at the end of the session. \nDetails:\nDate: Thursday April 16\, 2020\nTime: 10 -11:30 AM Pacific time \nSuggested audience:\n\nHIV and hepatitis C organization staff and volunteers\, including harm reduction workers\nCommunity members and other allies\nResearchers\nPeople interested in the epidemiology of infectious disease in BC\n\nPlease read this before you register\nAfter registration you should receive a confirmation email. SAVE THE CONFIRMATION EMAIL as it provides your unique link to get into the webinar. Check your Junk folder in email if it doesn’t arrive within an hour. \nIf you DO NOT receive an email within an hour of registering\, please EMAIL simon@pacificaidsnetwork.org as soon as you realize this. We won’t be able to provide access to links on the morning of the webinar as we will be setting up. \nRegister HERE
URL:https://scienceinvancouver.com/event/webinar-research-update-from-the-bc-htc-and-community-implications-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/BCHTC-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T151417
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:10962-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T151417
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:26130-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T151417
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:27745-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T151417
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:30828-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200416T130000
DTEND;TZID=America/Vancouver:20200416T134500
DTSTAMP:20260408T151417
CREATED:20200403T202418Z
LAST-MODIFIED:20200403T202418Z
UID:32288-1587042000-1587044700@scienceinvancouver.com
SUMMARY:LARGER THAN LIFE SCIENCE | Race for a Cure
DESCRIPTION:Race for a Cure\nThe Work Behind a Coronavirus Vaccine\nFireside Chat with Claes Gustafsson of ATUM\nAmidst global concerns about the coronavirus outbreak\, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat\, hear from ATUM’s Co-Founder\, Claes Gustafsson\, on the technology behind the cure and how the biotech community is banding together for the collective good. \nSpeakers:\nDr. Claes Gustafsson\, Co-Founder and Chief Commercial Officer\, ATUM \nDerrick Rowe\, PhD\, Associate\, Patents and Innovations\, Wilson Sonsini \n••• \nDownload the free Zoom app ahead of time to prepare for the webinar
URL:https://scienceinvancouver.com/event/larger-than-life-science-race-for-a-cure-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/LARGER-THAN-LIFE-SCIENCE-Race-for-a-Cure.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T151417
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:11105-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T151417
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:26141-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T151417
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:27756-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T151417
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:30839-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200417T110000
DTEND;TZID=America/Vancouver:20200419T200000
DTSTAMP:20260408T151417
CREATED:20200415T210805Z
LAST-MODIFIED:20200415T210805Z
UID:32299-1587121200-1587326400@scienceinvancouver.com
SUMMARY:Together Vs. Virus Online Hackathon against COVID-19
DESCRIPTION:Inspired by online hackathons against COVID-19 happening in Europe\, a group of incubators\, universities and organizations across Canada including faculty member Scott Mallory’s ISM Arts & Culture have come together to launch Together Vs. Virus for diverse people and innovators to develop ways to address challenges faced in our communities resulting from the pandemic. \nPeople from all backgrounds are invited to work with others on creative solutions for topics including arts & culture; protection of risk groups; dissemination prevention; data & misinformation; economic impact; isolation & mental health; hospital & medical care; family & kids; education; home office & teamwork; crime reduction; support & solidarity; after the crisis and more. Technical know-how is not required\, and participants represent a broad and diverse range of skills and perspectives. \nWays to participate include mentoring for projects\, tackling and answering challenges\, and proposing challenges. The three-day event includes presentations\, how-to sessions\, team-building\, mentoring\, updates\, tech support\, and pitches throughout each day\, and offers morning energizers and evening DJ sets\, concerts\, and live-coding.
URL:https://scienceinvancouver.com/event/together-vs-virus-online-hackathon-against-covid-19-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Together-vs-virus-online-hackathon-against-COVID19-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T151417
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:10894-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T151417
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:26124-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T151417
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:27739-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T151417
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:30822-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T151417
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:32282-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T151417
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:11123-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T151417
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:26143-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T151417
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:27758-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T151417
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:30841-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T151417
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:32301-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR